ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2024

Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France.

Matthieu Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.